One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Alcohol and health: time for an overdue conversation
doi : 10.1016/S2468-1253(20)30016-9
Volume 5, Issue 3, March 2020, Page 229
Addressing the global cirrhosis epidemic: one size will not fit all
Peter LWangaJennifer AFlemmingab
Extracting the benefits of berberine for colorectal cancer
SoheeKwonaAndrew TChanabc
Biological therapy and recurrent cancer: a threat no more?
Berkeley NLimketkaia
Charging forward in locally advanced pancreatic cancer
JenniferSegaraRachna TShroffa
Fatty liver disease: putting the spotlight on a silent menace for young adults
ElisabettaBugianesia
Hepatitis D virus in Uzbekistan
MalikaKhodjaevaaNargizIbadullaevaaAzizaKhikmatullaevaaElizavetaJoldasovaaSharapovSaidaAhmedovaShahnozaaUmedIsmoilovbGian PaoloCavigliacMarioRizzettocErkinMusabaeva
Global disparities in faecal microbiota transplantation research
Scott WOlesenaPratikPanchalaJustinChenaShrishBudreeaMajdiOsmana
Psychedelics for alcohol use disorder: state of the research
Talha KhanBurki
The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
Berberine versus placebo for the prevention of recurrence of colorectal adenoma: a multicentre, double-blinded, randomised controlled study
ProfYing-XuanChenMDa†Qin-YanGaoMDa†Tian-HuiZouMDa†ProfBang-MaoWangMDb†ProfSi-DeLiuMDc†ProfJian-QiuShengMDd†ProfJian-LinRenMDe†ProfXiao-PingZouMDf†ProfZhan-JuLiuMDg†Yan-YanSongPhDhProfBingXiaoMDcXiao-MinSunMDgXiao-TanDouMDfHai-LongCaoMDbXiao-NingYangMDeNaLiMDdQianKangMDdWeiZhuMDc…ProfJing-YuanFangMDa
Anti-tumour necrosis factor-α therapy and recurrent or new primary cancers in patients with inflammatory bowel disease, rheumatoid arthritis, or psoriasis and previous cancer in Denmark: a nationwide, population-based cohort study
Akbar KWaljeeMDabcProfPeter D RHigginsMDcCamilla BJensenPhDeMarieVillumsenPhDeShirley ACohen-MekelburgMDabcBeth IWallaceMDabdJeffrey ABerinsteinMDbcKristine HAllinPhDeProfTineJessMDefg
Nab-paclitaxel plus gemcitabine in patients with locally advanced pancreatic cancer (LAPACT): a multicentre, open-label phase 2 study
ProfPhilip APhilipMDaProfJillLacyMDbFabiennePortalesMDcProfAlbertoSobreroMDdRobertoPazo-CidMDeProfJosé LManzano MozoMDfEdward JKimMDgScotDowdenMDhAhmedZakariMDiProfChristopheBorgMDjEricTerrebonneMDkFernandoRiveraMDlJavierSastreMDmVenuBathiniMDnDanielLópez-TrabadaMDoJamilAsselahMDpMuhammad WasifSaifMDqJackShiansong LiPhDr…ProfPascalHammelMDs
Prevalence of steatosis and fibrosis in young adults in the UK: a population-based study
Kushala W MAbeysekeraMRCPabGwen SFernandesPhDaGemmaHammertonPhDaAndrew JPortalFRCPbFiona HGordonFRCPbJonHeronPhDaProfMatthewHickmanPhDa
Current and potential treatments for primary biliary cholangitis
Raj AShahMDaKris VKowdleyMDa
New advances in the treatment of paediatric functional abdominal pain disorders
Neha RSantucciMDabMiguelSapsMDcMiranda Avan TilburgPhDdef
